<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="publisher-id">nar</journal-id>
    <journal-title-group>
      <journal-title>Nucleic Acids Research</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0305-1048</issn>
    <issn pub-type="epub">1362-4962</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">8728115</article-id>
    <article-id pub-id-type="pmid">34534336</article-id>
    <article-id pub-id-type="doi">10.1093/nar/gkab810</article-id>
    <article-id pub-id-type="publisher-id">gkab810</article-id>
    <article-categories>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI00010</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Database Issue</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>GPEdit: the genetic and pharmacogenomic landscape of A-to-I RNA editing in cancers</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Ruan</surname>
          <given-names>Hang</given-names>
        </name>
        <!--hang.ruan@hotmail.com-->
        <aff><institution>Department of Biochemistry and Molecular Biology, McGovern Medical School at The University of Texas Health Science Center at Houston</institution>, <addr-line>Houston</addr-line>, <addr-line>TX</addr-line> <addr-line>77030</addr-line>, <country country="US">USA</country></aff>
        <xref rid="COR2" ref-type="corresp"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Li</surname>
          <given-names>Qiang</given-names>
        </name>
        <aff><institution>Center for Epigenetics and Disease Prevention, Institute of Biosciences and Technology, Texas A&amp;M University</institution>, <addr-line>Houston</addr-line>, <addr-line>TX</addr-line> <addr-line>77030</addr-line>, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Liu</surname>
          <given-names>Yuan</given-names>
        </name>
        <aff><institution>Center for Epigenetics and Disease Prevention, Institute of Biosciences and Technology, Texas A&amp;M University</institution>, <addr-line>Houston</addr-line>, <addr-line>TX</addr-line> <addr-line>77030</addr-line>, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Liu</surname>
          <given-names>Yaoming</given-names>
        </name>
        <aff><institution>Department of Biochemistry and Molecular Biology, McGovern Medical School at The University of Texas Health Science Center at Houston</institution>, <addr-line>Houston</addr-line>, <addr-line>TX</addr-line> <addr-line>77030</addr-line>, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Lussier</surname>
          <given-names>Charles</given-names>
        </name>
        <aff><institution>Center for Epigenetics and Disease Prevention, Institute of Biosciences and Technology, Texas A&amp;M University</institution>, <addr-line>Houston</addr-line>, <addr-line>TX</addr-line> <addr-line>77030</addr-line>, <country country="US">USA</country></aff>
        <aff><institution>Department of Computer Science and Statistics, Rice University</institution>, <addr-line>Houston</addr-line>, <addr-line>TX</addr-line> <addr-line>77030</addr-line>, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Diao</surname>
          <given-names>Lixia</given-names>
        </name>
        <aff><institution>Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center</institution>, <addr-line>Houston</addr-line>, <addr-line>TX</addr-line> <addr-line>77030</addr-line>, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7380-2640</contrib-id>
        <name>
          <surname>Han</surname>
          <given-names>Leng</given-names>
        </name>
        <!--leng.han@tamu.edu-->
        <aff><institution>Department of Biochemistry and Molecular Biology, McGovern Medical School at The University of Texas Health Science Center at Houston</institution>, <addr-line>Houston</addr-line>, <addr-line>TX</addr-line> <addr-line>77030</addr-line>, <country country="US">USA</country></aff>
        <aff><institution>Center for Epigenetics and Disease Prevention, Institute of Biosciences and Technology, Texas A&amp;M University</institution>, <addr-line>Houston</addr-line>, <addr-line>TX</addr-line> <addr-line>77030</addr-line>, <country country="US">USA</country></aff>
        <aff><institution>Department of Translational Medical Sciences, College of Medicine, Texas A&amp;M University</institution>, <addr-line>Houston</addr-line>, <addr-line>TX</addr-line> <addr-line>77030</addr-line>, <country country="US">USA</country></aff>
        <xref rid="COR1" ref-type="corresp"/>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="COR1">To whom correspondence should be addressed. Tel: +1 713 677 7663; Email: <email>leng.han@tamu.edu</email></corresp>
      <corresp id="COR2">Correspondence may also be addressed to Hang Ruan. Email: <email>hang.ruan@hotmail.com</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <day>07</day>
      <month>1</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2021-09-17">
      <day>17</day>
      <month>9</month>
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>17</day>
      <month>9</month>
      <year>2021</year>
    </pub-date>
    <volume>50</volume>
    <issue>D1</issue>
    <fpage>D1231</fpage>
    <lpage>D1237</lpage>
    <history>
      <date date-type="accepted">
        <day>06</day>
        <month>9</month>
        <year>2021</year>
      </date>
      <date date-type="rev-recd">
        <day>27</day>
        <month>8</month>
        <year>2021</year>
      </date>
      <date date-type="received">
        <day>05</day>
        <month>8</month>
        <year>2021</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2021. Published by Oxford University Press on behalf of Nucleic Acids Research.</copyright-statement>
      <copyright-year>2022</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="gkab810.pdf"/>
    <abstract>
      <title>Abstract</title>
      <p>Altered A-to-I RNA editing has been widely observed in many human cancers and some editing sites are associated with drug sensitivity, implicating its therapeutic potential. Increasing evidence has demonstrated that a quantitative trait loci mapping approach is effective to understanding the genetic basis of RNA editing. We systematically performed RNA editing quantitative trait loci (edQTL) analysis in 33 human cancer types for &gt;10 000 cancer samples and identified 320 029 edQTLs. We also identified 1688 ed-QTLs associated with patient overall survival and 4672 ed-QTLs associated with GWAS risk loci. Furthermore, we demonstrated the associations between RNA editing and &gt;1000 anti-cancer drug response with ∼3.5 million significant associations. We developed GPEdit (<ext-link xlink:href="https://hanlab.uth.edu/GPEdit/" ext-link-type="uri">https://hanlab.uth.edu/GPEdit/</ext-link>) to facilitate a global map of the genetic and pharmacogenomic landscape of RNA editing. GPEdit is a user-friendly and comprehensive database that provides an opportunity for a better understanding of the genetic impact and the effects on drug response of RNA editing in cancers.</p>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Human Genome Research Institute</institution>
            <institution-id institution-id-type="DOI">10.13039/100000051</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>R01HG011633</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Institute of Aging</institution>
          </institution-wrap>
        </funding-source>
        <award-id>R03AG070417</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Cancer Institute</institution>
            <institution-id institution-id-type="DOI">10.13039/100000054</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>R01CA262623</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Institutes of Health</institution>
            <institution-id institution-id-type="DOI">10.13039/100000002</institution-id>
          </institution-wrap>
        </funding-source>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Cancer Prevention Research Institute of Texas</institution>
            <institution-id institution-id-type="DOI">10.13039/100004917</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>RR150085</award-id>
        <award-id>RP190570</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Texas A&amp;M Institute of Biosciences and Technology</institution>
          </institution-wrap>
        </funding-source>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="7"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec sec-type="intro" id="SEC1">
    <title>INTRODUCTION</title>
    <p>RNA editing is a unique type of post-transcriptional modification that alters specific nucleotide sequences originated from one organism's genome. The major form of RNA editing in metazoans is Adenosine to Inosine (A-to-I), a process that is catalyzed by the adenosine deaminase acting on RNA (ADAR) enzymes (<xref rid="B1" ref-type="bibr">1</xref>,<xref rid="B2" ref-type="bibr">2</xref>). RNA editing, for its potential effects on transcript functions, has been associated with human diseases such as neurological disorders (<xref rid="B3" ref-type="bibr">3</xref>) and carcinoma in multiple tissue types (<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B5" ref-type="bibr">5</xref>). Previously, the pan-cancer A-to-I editome has been comprehensively profiled using RNA-seq data (<xref rid="B6" ref-type="bibr">6</xref>), and the genome-wide altered A-to-I RNA editing patterns are observed across multiple cancer types. Those RNA editing events identified in tumors are contributing to transcript complexity, or could further increase diversity at proteomic levels, that eventually affect functions of cancer cells (<xref rid="B7" ref-type="bibr">7</xref>).</p>
    <p>Previous works demonstrated that a quantitative trait loci (QTL) mapping approach is effective to understand the genetic basis of multiple molecular features in human cancers, e.g. gene expression, methylation, and alternative splicing (<xref rid="B8" ref-type="bibr">8–10</xref>). Several studies have been prioritizing the significance of RNA editing QTL (edQTL) in understanding relations between genetic variation and RNA editing functions (<xref rid="B11" ref-type="bibr">11–14</xref>). In these studies, the <italic toggle="yes">cis</italic>-regulatory mechanism of RNA editing patterns has been examined in animal models or normal human tissues. Genetic variants such as Single Nucleotide Polymorphism (SNP) that potentially affect RNA secondary structure are partially accounted for by the altered editing frequency. In human cancers, we have shown that RNA editing events are closely linked to clinical information such as patient overall survival (<xref rid="B6" ref-type="bibr">6</xref>). More importantly, some non-synonymous editing sites are associated with drug sensitivity, implicating a therapeutic role of RNA editing as potential targets (<xref rid="B6" ref-type="bibr">6</xref>). In other human diseases, RNA editing has been emerging as a biomarker in predicting treatment outcomes such as adverse drug reactions (<xref rid="B15" ref-type="bibr">15</xref>).</p>
    <p>The significant impact of genetic variants on different noncoding RNAs (<xref rid="B16" ref-type="bibr">16</xref>,<xref rid="B17" ref-type="bibr">17</xref>) and post-transcriptional regulation are recognized recently (<xref rid="B18" ref-type="bibr">18</xref>). Furthermore, we previously demonstrated that RNA editing may impact on drug response (<xref rid="B6" ref-type="bibr">6</xref>), but the associations between drug response and RNA editing across large number of cancer samples are not investigated. Despite the importance of interpretation of the genetic and pharmacological landscape of RNA editing in human cancers, there are no data resources that provide either edQTL information or drug sensitivity relations of RNA editing on a large scale. To bridge this gap, we implemented a computational pipeline to systematically identify edQTLs in 33 cancer types incorporating ∼10 000 tumor samples from The Cancer Genome Atlas (TCGA). By adopting an established approach (<xref rid="B19" ref-type="bibr">19</xref>), we also imputed the drug response of TCGA patients from ∼1000 compounds in Genomics of Drug Sensitivity in Cancer (GDSC) (<xref rid="B20" ref-type="bibr">20</xref>) and Cancer Therapeutics Response Portal (CTRP) (<xref rid="B21" ref-type="bibr">21</xref>) and investigated their associations with RNA editing. The data were deposited into our newly developed database GPEdit (genetic, pharmacogenomic landscape of A-to-I RNA editing in cancers, <ext-link xlink:href="https://hanlab.uth.edu/GPEdit/" ext-link-type="uri">https://hanlab.uth.edu/GPEdit/</ext-link>).</p>
  </sec>
  <sec id="SEC2">
    <title>DATA COLLECTION AND PROCESSING</title>
    <sec id="SEC2-1">
      <title>TCGA genotype data pre-processing</title>
      <p>TCGA level 2 genotype data from Affymetrix SNP Array 6.0 were downloaded from the Genomic Data Commons data portal (GDC; <ext-link xlink:href="https://gdc.cancer.gov" ext-link-type="uri">https://gdc.cancer.gov</ext-link>) (Figure <xref rid="F1" ref-type="fig">1A</xref>). As described in our previous publications (<xref rid="B9" ref-type="bibr">9</xref>,<xref rid="B22" ref-type="bibr">22</xref>), autosomal variants imputation helps to increase power for QTL discovery. We used IMPUTE2 (<xref rid="B22" ref-type="bibr">22</xref>) along with 1000 genome Phase 3 as a reference panel to perform the two steps of pre-phasing and autosomal variants imputation. Following quality control criteria were considered to exclude SNPs after imputation: (i) imputation score INFO &lt; 0.4; (ii) minor allele frequency (MAF) &lt; 0.05; (iii) SNP missing rate ≥0.05 for best-guessed genotypes with posterior probability ≥0.9 and (iv) Hardy–Weinberg equilibrium <italic toggle="yes">P</italic>-value &lt; 1 × 10<sup>–6</sup>.</p>
      <fig position="float" id="F1">
        <label>Figure 1.</label>
        <caption>
          <p>Analytic pipeline for data processing in GPEdit. (<bold>A</bold>) The pipeline to identify edQTLs, including processing and quality control of genotype data and RNA editing profiles, applying GLiMMPS model to identify edQTLs and crossmatch with survival information and GWAS catalogs. (<bold>B</bold>) The pipeline to identify drug response associated RNA editing events, including patients’ drug response imputation and large-scale correlation tests. (<bold>C</bold>) GPEdit database infrastructure.</p>
        </caption>
        <graphic xlink:href="gkab810fig1" position="float"/>
      </fig>
    </sec>
    <sec id="SEC2-2">
      <title>Profiling of pan-cancer A-to-I RNA editing</title>
      <p>We have previously developed a computational pipeline to characterize A-to-I RNA editing profiles in 17 TCGA cancer types following a RADAR reference panel (<xref rid="B23" ref-type="bibr">23</xref>) of ∼1.4 million A-to-I RNA editing sites (<xref rid="B6" ref-type="bibr">6</xref>). Here, we expanded our data collection to 33 cancer types following an updated reference panel of ∼4.5 million sites (<xref rid="B24" ref-type="bibr">24</xref>). We downloaded RNA-seq BAM files of 10 179 patient tumor samples from the GDC data portal. For sequence quality control, we only considered A-to-I RNA editing sites with at least 10 high-quality reads (base quality score ≥ 30) covered with at least two high-quality reads supporting the editing events (<xref rid="B25" ref-type="bibr">25</xref>). We further selected editing sites with editing frequency (edited reads / covered reads) significantly greater than 0.1% (binomial test with false discover rate controlled at 5%) (<xref rid="B25" ref-type="bibr">25</xref>) for the following edQTL analysis. We also excluded editing sites overlapping with variates annotated in dbSNP (version 138) and TCGA MC3 somatic mutations (<xref rid="B26" ref-type="bibr">26</xref>). To ensure sufficient editing frequency variations among cancer patients, a filter of a minimum 10% difference between the editing frequency of the 90% quantile and the 10% quantile across all tumor samples was implemented (<xref rid="B14" ref-type="bibr">14</xref>).</p>
    </sec>
    <sec id="SEC2-3">
      <title>Identification of edQTLs</title>
      <p>To emphasize the cis-regulatory role of detected edQTLs, only SNPs within 200 kb of editing sites were included in our analysis (<xref rid="B14" ref-type="bibr">14</xref>). To test the associations between SNPs and A-to-I RNA editing frequencies, we adopted a generalized linear mixed model GLiMMPS (<xref rid="B27" ref-type="bibr">27</xref>), which was applied in edQTL analysis (<xref rid="B14" ref-type="bibr">14</xref>). For each editing site, the edQTL was defined as the closest SNP with the most significant GLiMMPS <italic toggle="yes">P</italic>-value. For edQTLs identified in each cancer type, false discover rate (FDR) was controlled as &lt;0.01.</p>
    </sec>
    <sec id="SEC2-4">
      <title>Identification of edQTLs associated with survival and GWAS risk loci</title>
      <p>EdQTLs were further examined against patients' overall survival time. For each edQTL, tumor samples were classified into three groups by their genotypes and log-rank tests were performed on them to examine the significance of the overall survival time difference among groups. Within each cancer type, an edQTL with FDR &lt;0.1 was defined as survival associated edQTL. Kaplan-Meier (KM) curves were used to visualize the differences between groups.</p>
      <p>Genome-wide association studies (GWASs) have been contributing to understanding relations between genetic risk loci and complex diseases (<xref rid="B28" ref-type="bibr">28</xref>). Here, we downloaded available risk tag SNPs from the NHGRI-EBI GWAS catalog (<ext-link xlink:href="http://www.ebi.ac.uk/gwas/" ext-link-type="uri">http://www.ebi.ac.uk/gwas/</ext-link>, access on September 2020) (<xref rid="B29" ref-type="bibr">29</xref>). GWAS linkage disequilibrium (LD) regions of these risk tags SNPs were obtained from the SNAP database (<ext-link xlink:href="https://data.broadinstitute.org/mpg/snpsnap" ext-link-type="uri">https://data.broadinstitute.org/mpg/snpsnap</ext-link>) (<xref rid="B30" ref-type="bibr">30</xref>). The European (EUR) population in the 1000G Phase 3 dataset was selected with LD cut-off <italic toggle="yes">R</italic><sup>2</sup> over 0.5. EdQTLs overlapped with GWAS tag SNPs were defined as GWAS associated edQTLs.</p>
    </sec>
    <sec id="SEC2-5">
      <title>Identification of drug response associated editing events</title>
      <p>Recent studies demonstrated the significance of evaluating the drug response in patient samples (<xref rid="B31" ref-type="bibr">31</xref>,<xref rid="B32" ref-type="bibr">32</xref>). In this study, we adopted a previously established approach to impute the drug response of TCGA patient samples (idwas, <ext-link xlink:href="https://osf.io/yatu3/" ext-link-type="uri">https://osf.io/yatu3/</ext-link>) (<xref rid="B19" ref-type="bibr">19</xref>) and expanded to ∼1000 anti-cancer drugs available in other drug response data resources such as GDSC2 and CTRP (<xref rid="B20" ref-type="bibr">20</xref>,<xref rid="B21" ref-type="bibr">21</xref>). For each cancer type, we used the ‘rcorr’ function in the ‘Hmisc’ package to perform a large-scale Spearman Correlation test between RNA editing and drug response. We set a minimum of 50 samples of paired RNA editing frequency and imputed drug response. Editing-drug pairs with absolute Spearman Correlation over 0.3 and FDR &lt;0.01 were considered as a significant association.</p>
    </sec>
  </sec>
  <sec id="SEC3">
    <title>DATABASE CONTENT AND USAGE</title>
    <sec id="SEC3-1">
      <title>Data summary</title>
      <p>In the GPEdit data portal, we performed a comprehensive edQTL analysis across 33 TCGA cancer types to understand the genetic basis of the cis-regulatory mechanism in human cancers (Table <xref rid="tbl1" ref-type="table">1</xref>). The total number of edQTLs detected in 33 cancer types was 320 029, of which around 10% edQTLs (31,842) were detected in more than one cancer type. The numbers of edQTLs identified in each cancer type were ranging 776 in Adrenocortical Carcinoma (ACC) to 41 832 in Stomach Adenocarcinoma (STAD). The power of QTL detection increases with cohort samples size (<italic toggle="yes">R</italic>s = 0.73, <italic toggle="yes">P</italic> = 1.19 × 10<sup>–6</sup>), which is consistent with our previous pan-cancer QTL studies (<xref rid="B10" ref-type="bibr">10</xref>,<xref rid="B16" ref-type="bibr">16</xref>). The total number of survival-associated edQTLs is 1,688, of which the highest is 243 in Esophageal Carcinoma (ESCA) and the lowest is zero in Glioblastoma multiforme (GBM) (Table <xref rid="tbl1" ref-type="table">1</xref>). A total of 4672 GWAS-associated edQTLs were found, of which the highest is 607 in STAD and the lowest is 14 in Uveal Melanoma (UVM). We identified a total of 3 481 011 significant associations between drug response and editing events in 31 cancer types with sample size over 50. The number of significant pairs of associations ranged from nine in ACC to 658 619 in Thymoma (THYM) (Table <xref rid="tbl1" ref-type="table">1</xref>).</p>
      <table-wrap position="float" id="tbl1">
        <label>Table 1.</label>
        <caption>
          <p>Data Summary of edQTLs for each cancer type in GPEdit</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th rowspan="1" colspan="1">Cancer type</th>
              <th rowspan="1" colspan="1">#Sample</th>
              <th rowspan="1" colspan="1">#Editing events</th>
              <th rowspan="1" colspan="1">#edQTLs</th>
              <th rowspan="1" colspan="1">#Survival associated edQTLs</th>
              <th rowspan="1" colspan="1">#GWAS associated edQTLs</th>
              <th rowspan="1" colspan="1">#Editing drug pairs</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td rowspan="1" colspan="1">ACC</td>
              <td rowspan="1" colspan="1">79</td>
              <td rowspan="1" colspan="1">5906</td>
              <td rowspan="1" colspan="1">776</td>
              <td rowspan="1" colspan="1">4</td>
              <td rowspan="1" colspan="1">22</td>
              <td rowspan="1" colspan="1">9</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">BLCA</td>
              <td rowspan="1" colspan="1">408</td>
              <td rowspan="1" colspan="1">22 535</td>
              <td rowspan="1" colspan="1">7800</td>
              <td rowspan="1" colspan="1">69</td>
              <td rowspan="1" colspan="1">133</td>
              <td rowspan="1" colspan="1">187 275</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">BRCA</td>
              <td rowspan="1" colspan="1">1092</td>
              <td rowspan="1" colspan="1">52 158</td>
              <td rowspan="1" colspan="1">15 668</td>
              <td rowspan="1" colspan="1">20</td>
              <td rowspan="1" colspan="1">235</td>
              <td rowspan="1" colspan="1">228 675</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">CESC</td>
              <td rowspan="1" colspan="1">304</td>
              <td rowspan="1" colspan="1">19 290</td>
              <td rowspan="1" colspan="1">7046</td>
              <td rowspan="1" colspan="1">49</td>
              <td rowspan="1" colspan="1">99</td>
              <td rowspan="1" colspan="1">47 386</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">CHOL</td>
              <td rowspan="1" colspan="1">37</td>
              <td rowspan="1" colspan="1">9 383</td>
              <td rowspan="1" colspan="1">2075</td>
              <td rowspan="1" colspan="1">8</td>
              <td rowspan="1" colspan="1">36</td>
              <td rowspan="1" colspan="1">0</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">COAD</td>
              <td rowspan="1" colspan="1">456</td>
              <td rowspan="1" colspan="1">20 355</td>
              <td rowspan="1" colspan="1">6910</td>
              <td rowspan="1" colspan="1">4</td>
              <td rowspan="1" colspan="1">97</td>
              <td rowspan="1" colspan="1">78 557</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">DLBC</td>
              <td rowspan="1" colspan="1">48</td>
              <td rowspan="1" colspan="1">6 931</td>
              <td rowspan="1" colspan="1">1569</td>
              <td rowspan="1" colspan="1">16</td>
              <td rowspan="1" colspan="1">18</td>
              <td rowspan="1" colspan="1">0</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">ESCA</td>
              <td rowspan="1" colspan="1">164</td>
              <td rowspan="1" colspan="1">95 264</td>
              <td rowspan="1" colspan="1">39 244</td>
              <td rowspan="1" colspan="1">243</td>
              <td rowspan="1" colspan="1">575</td>
              <td rowspan="1" colspan="1">42 208</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">GBM</td>
              <td rowspan="1" colspan="1">149</td>
              <td rowspan="1" colspan="1">27 316</td>
              <td rowspan="1" colspan="1">7794</td>
              <td rowspan="1" colspan="1">0</td>
              <td rowspan="1" colspan="1">113</td>
              <td rowspan="1" colspan="1">72 277</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">HNSC</td>
              <td rowspan="1" colspan="1">501</td>
              <td rowspan="1" colspan="1">16 371</td>
              <td rowspan="1" colspan="1">6098</td>
              <td rowspan="1" colspan="1">24</td>
              <td rowspan="1" colspan="1">112</td>
              <td rowspan="1" colspan="1">85 168</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">KICH</td>
              <td rowspan="1" colspan="1">66</td>
              <td rowspan="1" colspan="1">12 841</td>
              <td rowspan="1" colspan="1">3 238</td>
              <td rowspan="1" colspan="1">8</td>
              <td rowspan="1" colspan="1">42</td>
              <td rowspan="1" colspan="1">60</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">KIRC</td>
              <td rowspan="1" colspan="1">530</td>
              <td rowspan="1" colspan="1">43 326</td>
              <td rowspan="1" colspan="1">17 793</td>
              <td rowspan="1" colspan="1">37</td>
              <td rowspan="1" colspan="1">267</td>
              <td rowspan="1" colspan="1">192 376</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">KIRP</td>
              <td rowspan="1" colspan="1">289</td>
              <td rowspan="1" colspan="1">26 742</td>
              <td rowspan="1" colspan="1">11 499</td>
              <td rowspan="1" colspan="1">145</td>
              <td rowspan="1" colspan="1">144</td>
              <td rowspan="1" colspan="1">73 399</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">LAML</td>
              <td rowspan="1" colspan="1">151</td>
              <td rowspan="1" colspan="1">46 633</td>
              <td rowspan="1" colspan="1">9815</td>
              <td rowspan="1" colspan="1">30</td>
              <td rowspan="1" colspan="1">142</td>
              <td rowspan="1" colspan="1">1512</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">LGG</td>
              <td rowspan="1" colspan="1">455</td>
              <td rowspan="1" colspan="1">25 314</td>
              <td rowspan="1" colspan="1">9042</td>
              <td rowspan="1" colspan="1">44</td>
              <td rowspan="1" colspan="1">123</td>
              <td rowspan="1" colspan="1">339 182</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">LIHC</td>
              <td rowspan="1" colspan="1">371</td>
              <td rowspan="1" colspan="1">19 884</td>
              <td rowspan="1" colspan="1">7495</td>
              <td rowspan="1" colspan="1">68</td>
              <td rowspan="1" colspan="1">101</td>
              <td rowspan="1" colspan="1">75 823</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">LUAD</td>
              <td rowspan="1" colspan="1">515</td>
              <td rowspan="1" colspan="1">32 510</td>
              <td rowspan="1" colspan="1">13 504</td>
              <td rowspan="1" colspan="1">40</td>
              <td rowspan="1" colspan="1">199</td>
              <td rowspan="1" colspan="1">38 679</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">LUSC</td>
              <td rowspan="1" colspan="1">501</td>
              <td rowspan="1" colspan="1">33 142</td>
              <td rowspan="1" colspan="1">12 936</td>
              <td rowspan="1" colspan="1">47</td>
              <td rowspan="1" colspan="1">204</td>
              <td rowspan="1" colspan="1">25 923</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">MESO</td>
              <td rowspan="1" colspan="1">86</td>
              <td rowspan="1" colspan="1">10 573</td>
              <td rowspan="1" colspan="1">2747</td>
              <td rowspan="1" colspan="1">20</td>
              <td rowspan="1" colspan="1">44</td>
              <td rowspan="1" colspan="1">55</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">OV</td>
              <td rowspan="1" colspan="1">389</td>
              <td rowspan="1" colspan="1">69 877</td>
              <td rowspan="1" colspan="1">18 314</td>
              <td rowspan="1" colspan="1">16</td>
              <td rowspan="1" colspan="1">263</td>
              <td rowspan="1" colspan="1">30 375</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">PAAD</td>
              <td rowspan="1" colspan="1">177</td>
              <td rowspan="1" colspan="1">16 505</td>
              <td rowspan="1" colspan="1">5974</td>
              <td rowspan="1" colspan="1">26</td>
              <td rowspan="1" colspan="1">100</td>
              <td rowspan="1" colspan="1">30 162</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">PCPG</td>
              <td rowspan="1" colspan="1">179</td>
              <td rowspan="1" colspan="1">15 267</td>
              <td rowspan="1" colspan="1">5182</td>
              <td rowspan="1" colspan="1">86</td>
              <td rowspan="1" colspan="1">67</td>
              <td rowspan="1" colspan="1">21 983</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">PRAD</td>
              <td rowspan="1" colspan="1">496</td>
              <td rowspan="1" colspan="1">25 321</td>
              <td rowspan="1" colspan="1">10 643</td>
              <td rowspan="1" colspan="1">109</td>
              <td rowspan="1" colspan="1">139</td>
              <td rowspan="1" colspan="1">148 336</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">READ</td>
              <td rowspan="1" colspan="1">167</td>
              <td rowspan="1" colspan="1">11 630</td>
              <td rowspan="1" colspan="1">3842</td>
              <td rowspan="1" colspan="1">11</td>
              <td rowspan="1" colspan="1">60</td>
              <td rowspan="1" colspan="1">340</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">SARC</td>
              <td rowspan="1" colspan="1">259</td>
              <td rowspan="1" colspan="1">19 277</td>
              <td rowspan="1" colspan="1">6794</td>
              <td rowspan="1" colspan="1">62</td>
              <td rowspan="1" colspan="1">86</td>
              <td rowspan="1" colspan="1">40 870</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">SKCM</td>
              <td rowspan="1" colspan="1">468</td>
              <td rowspan="1" colspan="1">22 969</td>
              <td rowspan="1" colspan="1">6519</td>
              <td rowspan="1" colspan="1">71</td>
              <td rowspan="1" colspan="1">94</td>
              <td rowspan="1" colspan="1">98 009</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">STAD</td>
              <td rowspan="1" colspan="1">380</td>
              <td rowspan="1" colspan="1">100 755</td>
              <td rowspan="1" colspan="1">41 832</td>
              <td rowspan="1" colspan="1">161</td>
              <td rowspan="1" colspan="1">607</td>
              <td rowspan="1" colspan="1">37 285</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">TGCT</td>
              <td rowspan="1" colspan="1">150</td>
              <td rowspan="1" colspan="1">16 689</td>
              <td rowspan="1" colspan="1">5 372</td>
              <td rowspan="1" colspan="1">133</td>
              <td rowspan="1" colspan="1">67</td>
              <td rowspan="1" colspan="1">511 418</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">THCA</td>
              <td rowspan="1" colspan="1">502</td>
              <td rowspan="1" colspan="1">26 644</td>
              <td rowspan="1" colspan="1">10 304</td>
              <td rowspan="1" colspan="1">95</td>
              <td rowspan="1" colspan="1">152</td>
              <td rowspan="1" colspan="1">395 504</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">THYM</td>
              <td rowspan="1" colspan="1">119</td>
              <td rowspan="1" colspan="1">16 027</td>
              <td rowspan="1" colspan="1">5251</td>
              <td rowspan="1" colspan="1">12</td>
              <td rowspan="1" colspan="1">80</td>
              <td rowspan="1" colspan="1">658 619</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">UCEC</td>
              <td rowspan="1" colspan="1">555</td>
              <td rowspan="1" colspan="1">28 222</td>
              <td rowspan="1" colspan="1">12 103</td>
              <td rowspan="1" colspan="1">21</td>
              <td rowspan="1" colspan="1">161</td>
              <td rowspan="1" colspan="1">4794</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">UCS</td>
              <td rowspan="1" colspan="1">56</td>
              <td rowspan="1" colspan="1">11 231</td>
              <td rowspan="1" colspan="1">3339</td>
              <td rowspan="1" colspan="1">1</td>
              <td rowspan="1" colspan="1">76</td>
              <td rowspan="1" colspan="1">81</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">UVM</td>
              <td rowspan="1" colspan="1">80</td>
              <td rowspan="1" colspan="1">7239</td>
              <td rowspan="1" colspan="1">1511</td>
              <td rowspan="1" colspan="1">8</td>
              <td rowspan="1" colspan="1">14</td>
              <td rowspan="1" colspan="1">14 671</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
    </sec>
    <sec id="SEC3-2">
      <title>Web design and interface</title>
      <p>GPEdit data portal was constructed based on Django framework with Bootstrap as front-end web interface and SQLite as a back-end database tool (Figure <xref rid="F1" ref-type="fig">1C</xref>) (<xref rid="B33" ref-type="bibr">33</xref>). Various JavaScript libraries such as ‘DataTable’ were used in the web interface. R with ‘ggplot2’ package was used to produce figures that were deposited in GPEdit. GPEdit is freely available at (<ext-link xlink:href="https://hanlab.uth.edu/GPEdit" ext-link-type="uri">https://hanlab.uth.edu/GPEdit</ext-link>).</p>
      <p>There are four function modules available (Figure <xref rid="F2" ref-type="fig">2A</xref>) in GPEdit for data query: (i) ‘edQTL’ for querying identified edQTLs; (ii) ‘Survival-edQTL’ for querying edQTLs that have significant associations with patients’ survival; (iii) ‘GWAS-edQTL’ for querying edQTLs that may link with SNPs that annotated in GWAS studies and (iv) ‘Drug Response’ for querying significant drug associated RNA editing events. The GPEdit also provides query function by cancer types on its home page.</p>
      <fig position="float" id="F2">
        <label>Figure 2.</label>
        <caption>
          <p>Overview of the GPEdit database. (<bold>A</bold>) Four functional modules are provided in GPEdit. (<bold>B</bold>) Query web interface in the ‘edQTL’ module. (<bold>C</bold>) An example of query return table of the ‘edQTL’ module. (<bold>D</bold>) Examples of query return tables from the ‘Survival-edQTL’ module (upper panel), ‘GWAS-edQTL’ module (middle panel), and ‘Drug Response’ module (lower panel). (<bold>E</bold>) An example of a box plot visualizing one edQTL. (<bold>F</bold>) An example of Kaplan-Meier plot visualizing one survival associated edQTL.</p>
        </caption>
        <graphic xlink:href="gkab810fig2" position="float"/>
      </fig>
      <p>Within each query function module, queries be made using a set of user-defined criteria such as SNP id (e.g. rs11024008), a specific genomic location (e.g. chr1:150000000-160000000), or the gene symbol (e.g., ADAR) adjacent to RNA editing sites (Figure <xref rid="F2" ref-type="fig">2B</xref>). For example, in the ‘edQTL’ module, when a user chose the query option by ‘Adjacent Gene Symbol’ and type in ‘ADAR’. The text box would automatically match and autofill with available gene symbols for convenience. After clicking the ‘Query’ button, a table with query returns would appear, and results matched with ‘ADAR’ would be listed in the table (Figure <xref rid="F2" ref-type="fig">2C</xref>). For example, the table shows two edQTLs that are associated with the same RNA editing sites located at the 3’UTR region of the gene ADAR.</p>
      <p>For other modules, making a query is similar to the ‘edQTL’ module, while the query options could be different. For example, the ‘GWAS-edQTL’ module has an additional ‘Linkage disequilibrium’ cutoff choosing option. The query returns are also different among modules (Figure <xref rid="F2" ref-type="fig">2D</xref>). Some modules provide a data visualization option in the query returns table. For instance, the ‘edQTL’ module provides a box plot to visualize edQTLs’ impact on RNA editing frequencies among cancer samples (Figure <xref rid="F2" ref-type="fig">2E</xref>) and the ‘Survival-edQTL’ provides a Kaplan-Meier plot (KM plot) to visualize edQTLs’ association with patient's survival (Figure <xref rid="F2" ref-type="fig">2F</xref>). The box plot in Figure <xref rid="F2" ref-type="fig">2E</xref> shows an edQTL rs1127309 is significantly associated with RNA editing frequencies of an editing site located at the 3’UTR region of the gene ADAR. The KM plot in Figure <xref rid="F2" ref-type="fig">2F</xref> shows that an edQTL rs11167680 is significantly associated with patients' survival using the Log-rank test (<italic toggle="yes">P</italic> &lt; 0.0001), and the risk table is listed below the KM plot.</p>
      <p>Additionally, all the query return tables are searchable and can be downloaded in ‘Microsoft Excel’ compatible format. All the visualization plots can be saved in ‘png’ format as well as in ‘pdf’ format. A detailed tutorial of GPEdit can be found on the ‘Document’ page.</p>
    </sec>
  </sec>
  <sec id="SEC4">
    <title>SUMMARY AND FUTURE DIRECTIONS</title>
    <p>We systematically investigated the genetic and pharmacogenomic basis of A-to-I RNA editing events in 33 human cancers. We constructed a user-friendly database, GPEdit, for users to query, browse and download edQTLs. Huge amounts of vector diagrams of edQTL box plots and KM plots are provided. GPEdit could serve as an important resource for human cancer genetics and provide opportunities to bridge the knowledge gap from variants in sequence to RNA editing. In addition, GPEdit provides the associations between RNA editing and &gt;1000 anti-cancer drugs thus contributing to understanding the functional effects of RNA editing on drug response. Cancer Genomics is an explosively growing field in recent years (<xref rid="B33" ref-type="bibr">33–37</xref>), with the great effort from several large-scale consortiums, including TCGA, International Cancer Genome Consortium (<xref rid="B38" ref-type="bibr">38</xref>), as well as many other studies with a significant amount of data. We will periodically survey newly released cancer data resources with a considerable number of samples with matching genotype data, expression data, and drug response data. We will update GPEdit accordingly and maintain it as a useful resource for the research community.</p>
  </sec>
  <sec sec-type="data-availability" id="SEC5">
    <title>DATA AVAILABILITY</title>
    <p>GPEdit is a data resource portal that is freely available at (<ext-link xlink:href="https://hanlab.uth.edu/GPEdit" ext-link-type="uri">https://hanlab.uth.edu/GPEdit</ext-link>). Analytic codes for RNA editing calling and edQTL detection are available at GitHub site (<ext-link xlink:href="https://github.com/hr1912/GPEdit" ext-link-type="uri">https://github.com/hr1912/GPEdit</ext-link>).</p>
  </sec>
</body>
<back>
  <ack id="ACK1">
    <title>ACKNOWLEDGEMENTS</title>
    <p>National Human Genome Research Institute [R01HG011633 to L.H.]; National Institute of Aging [R03AG070417 to L.H.]; National Cancer Institute [R01CA262623 to L.H.] of the National Institutes of Health; Cancer Prevention Research Institute of Texas (CPRIT) [RR150085, RP190570] to the CPRIT Scholar in Cancer Research (to L.H.). We gratefully acknowledge contributions from TCGA Research Network. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.</p>
  </ack>
  <sec id="SEC6">
    <title>FUNDING</title>
    <p>National Human Genome Research Institute [R01HG011633 to L.H.]; National Institute of Aging [R03AG070417 to L.H.]; National Cancer Institute [R01CA262623 to L.H.] of the National Institutes of Health; Cancer Prevention Research Institute of Texas (CPRIT) [RR150085, RP190570] to the CPRIT Scholar in Cancer Research (to L.H.); C.L. is supported by Hamill Undergraduate Summer Research Program at the Texas A&amp;M Institute of Biosciences and Technology. Funding for open access charge: National Institutes of Health [R01HG011633].</p>
    <p><italic toggle="yes">Conflict of interest statement</italic>. None declared.</p>
  </sec>
  <ref-list id="REF1">
    <title>REFERENCES</title>
    <ref id="B1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Porath</surname><given-names>H.T.</given-names></string-name>, <string-name><surname>Knisbacher</surname><given-names>B.A.</given-names></string-name>, <string-name><surname>Eisenberg</surname><given-names>E.</given-names></string-name>, <string-name><surname>Levanon</surname><given-names>E.Y.</given-names></string-name></person-group><article-title>Massive A-to-I RNA editing is common across the Metazoa and correlates with dsRNA abundance</article-title>. <source>Genome Biol.</source><year>2017</year>; <volume>18</volume>:<fpage>185</fpage>.<pub-id pub-id-type="pmid">28969707</pub-id></mixed-citation>
    </ref>
    <ref id="B2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ruan</surname><given-names>H.</given-names></string-name>, <string-name><surname>Han</surname><given-names>L.</given-names></string-name></person-group><article-title>Regulatory RNA editing sites in cancer: prediction and beyond</article-title>. <source>EBioMedicine</source>. <year>2018</year>; <volume>27</volume>:<fpage>7</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">29273357</pub-id></mixed-citation>
    </ref>
    <ref id="B3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hwang</surname><given-names>T.</given-names></string-name>, <string-name><surname>Park</surname><given-names>C.K.</given-names></string-name>, <string-name><surname>Leung</surname><given-names>A.K.</given-names></string-name>, <string-name><surname>Gao</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Hyde</surname><given-names>T.M.</given-names></string-name>, <string-name><surname>Kleinman</surname><given-names>J.E.</given-names></string-name>, <string-name><surname>Rajpurohit</surname><given-names>A.</given-names></string-name>, <string-name><surname>Tao</surname><given-names>R.</given-names></string-name>, <string-name><surname>Shin</surname><given-names>J.H.</given-names></string-name>, <string-name><surname>Weinberger</surname><given-names>D.R.</given-names></string-name></person-group><article-title>Dynamic regulation of RNA editing in human brain development and disease</article-title>. <source>Nat. Neurosci.</source><year>2016</year>; <volume>19</volume>:<fpage>1093</fpage>–<lpage>1099</lpage>.<pub-id pub-id-type="pmid">27348216</pub-id></mixed-citation>
    </ref>
    <ref id="B4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Slotkin</surname><given-names>W.</given-names></string-name>, <string-name><surname>Nishikura</surname><given-names>K.</given-names></string-name></person-group><article-title>Adenosine-to-inosine RNA editing and human disease</article-title>. <source>Genome Med</source>. <year>2013</year>; <volume>5</volume>:<fpage>105</fpage>.<pub-id pub-id-type="pmid">24289319</pub-id></mixed-citation>
    </ref>
    <ref id="B5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gallo</surname><given-names>A.</given-names></string-name>, <string-name><surname>Vukic</surname><given-names>D.</given-names></string-name>, <string-name><surname>Michalik</surname><given-names>D.</given-names></string-name>, <string-name><surname>O’Connell</surname><given-names>M.A.</given-names></string-name>, <string-name><surname>Keegan</surname><given-names>L.P.</given-names></string-name></person-group><article-title>ADAR RNA editing in human disease; more to it than meets the I</article-title>. <source>Hum. Genet.</source><year>2017</year>; <volume>136</volume>:<fpage>1265</fpage>–<lpage>1278</lpage>.<pub-id pub-id-type="pmid">28913566</pub-id></mixed-citation>
    </ref>
    <ref id="B6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Han</surname><given-names>L.</given-names></string-name>, <string-name><surname>Diao</surname><given-names>L.</given-names></string-name>, <string-name><surname>Yu</surname><given-names>S.</given-names></string-name>, <string-name><surname>Xu</surname><given-names>X.</given-names></string-name>, <string-name><surname>Li</surname><given-names>J.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>R.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Werner</surname><given-names>H.M.J.</given-names></string-name>, <string-name><surname>Eterovic</surname><given-names>A.K.</given-names></string-name>, <string-name><surname>Yuan</surname><given-names>Y.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The genomic landscape and clinical relevance of A-to-I RNA editing in human cancers</article-title>. <source>Cancer Cell</source>. <year>2015</year>; <volume>28</volume>:<fpage>515</fpage>–<lpage>528</lpage>.<pub-id pub-id-type="pmid">26439496</pub-id></mixed-citation>
    </ref>
    <ref id="B7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Peng</surname><given-names>X.</given-names></string-name>, <string-name><surname>Xu</surname><given-names>X.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Hawke</surname><given-names>D.H.</given-names></string-name>, <string-name><surname>Yu</surname><given-names>S.</given-names></string-name>, <string-name><surname>Han</surname><given-names>L.</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Mojumdar</surname><given-names>K.</given-names></string-name>, <string-name><surname>Jeong</surname><given-names>K.J.</given-names></string-name>, <string-name><surname>Labrie</surname><given-names>M.</given-names></string-name><etal>et al</etal>.</person-group><article-title>A-to-I RNA editing contributes to proteomic diversity in cancer</article-title>. <source>Cancer Cell</source>. <year>2018</year>; <volume>33</volume>:<fpage>817</fpage>–<lpage>828</lpage>.<pub-id pub-id-type="pmid">29706454</pub-id></mixed-citation>
    </ref>
    <ref id="B8">
      <label>8.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gong</surname><given-names>J.</given-names></string-name>, <string-name><surname>Wan</surname><given-names>H.</given-names></string-name>, <string-name><surname>Mei</surname><given-names>S.</given-names></string-name>, <string-name><surname>Ruan</surname><given-names>H.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>C.</given-names></string-name>, <string-name><surname>Guo</surname><given-names>A.Y.</given-names></string-name>, <string-name><surname>Diao</surname><given-names>L.</given-names></string-name>, <string-name><surname>Miao</surname><given-names>X.</given-names></string-name>, <string-name><surname>Han</surname><given-names>L.</given-names></string-name></person-group><article-title>Pancan-meQTL: a database to systematically evaluate the effects of genetic variants on methylation in human cancer</article-title>. <source>Nucleic Acids Res.</source><year>2019</year>; <volume>47</volume>:<fpage>D1066</fpage>–<lpage>D1072</lpage>.<pub-id pub-id-type="pmid">30203047</pub-id></mixed-citation>
    </ref>
    <ref id="B9">
      <label>9.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gong</surname><given-names>J.</given-names></string-name>, <string-name><surname>Mei</surname><given-names>S.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>C.</given-names></string-name>, <string-name><surname>Xiang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Ye</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Feng</surname><given-names>J.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>R.</given-names></string-name>, <string-name><surname>Diao</surname><given-names>L.</given-names></string-name>, <string-name><surname>Guo</surname><given-names>A.Y.</given-names></string-name><etal>et al</etal>.</person-group><article-title>PancanQTL: systematic identification of cis-eQTLs and trans-eQTLs in 33 cancer types</article-title>. <source>Nucleic Acids Res.</source><year>2018</year>; <volume>46</volume>:<fpage>D971</fpage>–<lpage>D976</lpage>.<pub-id pub-id-type="pmid">29036324</pub-id></mixed-citation>
    </ref>
    <ref id="B10">
      <label>10.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tian</surname><given-names>J.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Mei</surname><given-names>S.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>N.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Ke</surname><given-names>J.</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Gong</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Zou</surname><given-names>D.</given-names></string-name>, <string-name><surname>Peng</surname><given-names>X.</given-names></string-name><etal>et al</etal>.</person-group><article-title>CancerSplicingQTL: a database for genome-wide identification of splicing QTLs in human cancer</article-title>. <source>Nucleic Acids Res.</source><year>2019</year>; <volume>47</volume>:<fpage>D909</fpage>–<lpage>D916</lpage>.<pub-id pub-id-type="pmid">30329095</pub-id></mixed-citation>
    </ref>
    <ref id="B11">
      <label>11.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Breen</surname><given-names>M.S.</given-names></string-name>, <string-name><surname>Dobbyn</surname><given-names>A.</given-names></string-name>, <string-name><surname>Li</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Roussos</surname><given-names>P.</given-names></string-name>, <string-name><surname>Hoffman</surname><given-names>G.E.</given-names></string-name>, <string-name><surname>Stahl</surname><given-names>E.</given-names></string-name>, <string-name><surname>Chess</surname><given-names>A.</given-names></string-name>, <string-name><surname>Sklar</surname><given-names>P.</given-names></string-name>, <string-name><surname>Li</surname><given-names>J.B.</given-names></string-name>, <string-name><surname>Devlin</surname><given-names>B.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Global landscape and genetic regulation of RNA editing in cortical samples from individuals with schizophrenia</article-title>. <source>Nat. Neurosci.</source><year>2019</year>; <volume>22</volume>:<fpage>1402</fpage>–<lpage>1412</lpage>.<pub-id pub-id-type="pmid">31455887</pub-id></mixed-citation>
    </ref>
    <ref id="B12">
      <label>12.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Park</surname><given-names>E.</given-names></string-name>, <string-name><surname>Jiang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Hao</surname><given-names>L.</given-names></string-name>, <string-name><surname>Hui</surname><given-names>J.</given-names></string-name>, <string-name><surname>Xing</surname><given-names>Y.</given-names></string-name></person-group><article-title>Genetic variation and microRNA targeting of A-to-I RNA editing fine tune human tissue transcriptomes</article-title>. <source>Genome Biol.</source><year>2021</year>; <volume>22</volume>:<fpage>77</fpage>.<pub-id pub-id-type="pmid">33685485</pub-id></mixed-citation>
    </ref>
    <ref id="B13">
      <label>13.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ramaswami</surname><given-names>G.</given-names></string-name>, <string-name><surname>Deng</surname><given-names>P.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>R.</given-names></string-name>, <string-name><surname>Anna Carbone</surname><given-names>M.</given-names></string-name>, <string-name><surname>Mackay</surname><given-names>T.F.C.</given-names></string-name>, <string-name><surname>Billy Li</surname><given-names>J.</given-names></string-name></person-group><article-title>Genetic mapping uncovers cis-regulatory landscape of RNA editing</article-title>. <source>Nat. Commun.</source><year>2015</year>; <volume>6</volume>:<fpage>8194</fpage>.<pub-id pub-id-type="pmid">26373807</pub-id></mixed-citation>
    </ref>
    <ref id="B14">
      <label>14.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Park</surname><given-names>E.</given-names></string-name>, <string-name><surname>Guo</surname><given-names>J.</given-names></string-name>, <string-name><surname>Shen</surname><given-names>S.</given-names></string-name>, <string-name><surname>Demirdjian</surname><given-names>L.</given-names></string-name>, <string-name><surname>Wu</surname><given-names>Y.N.</given-names></string-name>, <string-name><surname>Lin</surname><given-names>L.</given-names></string-name>, <string-name><surname>Xing</surname><given-names>Y.</given-names></string-name></person-group><article-title>Population and allelic variation of A-to-I RNA editing in human transcriptomes</article-title>. <source>Genome Biol.</source><year>2017</year>; <volume>18</volume>:<fpage>143</fpage>.<pub-id pub-id-type="pmid">28754146</pub-id></mixed-citation>
    </ref>
    <ref id="B15">
      <label>15.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>van der Laan</surname><given-names>S.</given-names></string-name>, <string-name><surname>Salvetat</surname><given-names>N.</given-names></string-name>, <string-name><surname>Weissmann</surname><given-names>D.</given-names></string-name>, <string-name><surname>Molina</surname><given-names>F.</given-names></string-name></person-group><article-title>Emerging RNA editing biomarkers will foster drug development</article-title>. <source>Drug Discov. Today</source>. <year>2017</year>; <volume>22</volume>:<fpage>1056</fpage>–<lpage>1063</lpage>.<pub-id pub-id-type="pmid">28188894</pub-id></mixed-citation>
    </ref>
    <ref id="B16">
      <label>16.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Ruan</surname><given-names>H.</given-names></string-name>, <string-name><surname>Li</surname><given-names>S.</given-names></string-name>, <string-name><surname>Ye</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Hong</surname><given-names>W.</given-names></string-name>, <string-name><surname>Gong</surname><given-names>J.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Jing</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>X.</given-names></string-name>, <string-name><surname>Diao</surname><given-names>L.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The genetic and pharmacogenomic landscape of snoRNAs in human cancer</article-title>. <source>Mol. Cancer</source>. <year>2020</year>; <volume>19</volume>:<fpage>108</fpage>.<pub-id pub-id-type="pmid">32576192</pub-id></mixed-citation>
    </ref>
    <ref id="B17">
      <label>17.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>J.</given-names></string-name>, <string-name><surname>Xue</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Amin</surname><given-names>M.T.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>W.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>W.</given-names></string-name>, <string-name><surname>Niu</surname><given-names>X.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>H.Y.</given-names></string-name>, <string-name><surname>Gong</surname><given-names>J.</given-names></string-name></person-group><article-title>ncRNA-eQTL: a database to systematically evaluate the effects of SNPs on non-coding RNA expression across cancer types</article-title>. <source>Nucleic Acids Res.</source><year>2020</year>; <volume>48</volume>:<fpage>D956</fpage>–<lpage>D963</lpage>.<pub-id pub-id-type="pmid">31410488</pub-id></mixed-citation>
    </ref>
    <ref id="B18">
      <label>18.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ye</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Diao</surname><given-names>L.</given-names></string-name>, <string-name><surname>Han</surname><given-names>L.</given-names></string-name></person-group><article-title>A multi-omics perspective of quantitative trait loci in precision medicine</article-title>. <source>Trends Genet.</source><year>2020</year>; <volume>36</volume>:<fpage>318</fpage>–<lpage>336</lpage>.<pub-id pub-id-type="pmid">32294413</pub-id></mixed-citation>
    </ref>
    <ref id="B19">
      <label>19.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Geeleher</surname><given-names>P.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>F.</given-names></string-name>, <string-name><surname>Gruener</surname><given-names>R.F.</given-names></string-name>, <string-name><surname>Nath</surname><given-names>A.</given-names></string-name>, <string-name><surname>Morrison</surname><given-names>G.</given-names></string-name>, <string-name><surname>Bhutra</surname><given-names>S.</given-names></string-name>, <string-name><surname>Grossman</surname><given-names>R.L.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>R.S.</given-names></string-name></person-group><article-title>Discovering novel pharmacogenomic biomarkers by imputing drug response in cancer patients from large genomics studies</article-title>. <source>Genome Res.</source><year>2017</year>; <volume>27</volume>:<fpage>1743</fpage>–<lpage>1751</lpage>.<pub-id pub-id-type="pmid">28847918</pub-id></mixed-citation>
    </ref>
    <ref id="B20">
      <label>20.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yang</surname><given-names>W.</given-names></string-name>, <string-name><surname>Soares</surname><given-names>J.</given-names></string-name>, <string-name><surname>Greninger</surname><given-names>P.</given-names></string-name>, <string-name><surname>Edelman</surname><given-names>E.J.</given-names></string-name>, <string-name><surname>Lightfoot</surname><given-names>H.</given-names></string-name>, <string-name><surname>Forbes</surname><given-names>S.</given-names></string-name>, <string-name><surname>Bindal</surname><given-names>N.</given-names></string-name>, <string-name><surname>Beare</surname><given-names>D.</given-names></string-name>, <string-name><surname>Smith</surname><given-names>J.A.</given-names></string-name>, <string-name><surname>Thompson</surname><given-names>I.R.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells</article-title>. <source>Nucleic Acids Res.</source><year>2013</year>; <volume>41</volume>:<fpage>D955</fpage>–<lpage>D961</lpage>.<pub-id pub-id-type="pmid">23180760</pub-id></mixed-citation>
    </ref>
    <ref id="B21">
      <label>21.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rees</surname><given-names>M.G.</given-names></string-name>, <string-name><surname>Seashore-Ludlow</surname><given-names>B.</given-names></string-name>, <string-name><surname>Cheah</surname><given-names>J.H.</given-names></string-name>, <string-name><surname>Adams</surname><given-names>D.J.</given-names></string-name>, <string-name><surname>Price</surname><given-names>E.V.</given-names></string-name>, <string-name><surname>Gill</surname><given-names>S.</given-names></string-name>, <string-name><surname>Javaid</surname><given-names>S.</given-names></string-name>, <string-name><surname>Coletti</surname><given-names>M.E.</given-names></string-name>, <string-name><surname>Jones</surname><given-names>V.L.</given-names></string-name>, <string-name><surname>Bodycombe</surname><given-names>N.E.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Correlating chemical sensitivity and basal gene expression reveals mechanism of action</article-title>. <source>Nat. Chem. Biol.</source><year>2016</year>; <volume>12</volume>:<fpage>109</fpage>–<lpage>116</lpage>.<pub-id pub-id-type="pmid">26656090</pub-id></mixed-citation>
    </ref>
    <ref id="B22">
      <label>22.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>van Leeuwen</surname><given-names>E.M.</given-names></string-name>, <string-name><surname>Kanterakis</surname><given-names>A.</given-names></string-name>, <string-name><surname>Deelen</surname><given-names>P.</given-names></string-name>, <string-name><surname>Kattenberg</surname><given-names>M.V.</given-names></string-name>, <string-name><surname>Genome of the Netherlands</surname><given-names>C.</given-names></string-name>, <string-name><surname>Slagboom</surname><given-names>P.E.</given-names></string-name>, <string-name><surname>de Bakker</surname><given-names>P.I.</given-names></string-name>, <string-name><surname>Wijmenga</surname><given-names>C.</given-names></string-name>, <string-name><surname>Swertz</surname><given-names>M.A.</given-names></string-name>, <string-name><surname>Boomsma</surname><given-names>D.I.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Population-specific genotype imputations using minimac or IMPUTE2</article-title>. <source>Nat. Protoc.</source><year>2015</year>; <volume>10</volume>:<fpage>1285</fpage>–<lpage>1296</lpage>.<pub-id pub-id-type="pmid">26226460</pub-id></mixed-citation>
    </ref>
    <ref id="B23">
      <label>23.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ramaswami</surname><given-names>G.</given-names></string-name>, <string-name><surname>Li</surname><given-names>J.B.</given-names></string-name></person-group><article-title>RADAR: a rigorously annotated database of A-to-I RNA editing</article-title>. <source>Nucleic Acids Res.</source><year>2014</year>; <volume>42</volume>:<fpage>D109</fpage>–<lpage>D113</lpage>.<pub-id pub-id-type="pmid">24163250</pub-id></mixed-citation>
    </ref>
    <ref id="B24">
      <label>24.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Picardi</surname><given-names>E.</given-names></string-name>, <string-name><surname>D’Erchia</surname><given-names>A.M.</given-names></string-name>, <string-name><surname>Lo Giudice</surname><given-names>C.</given-names></string-name>, <string-name><surname>Pesole</surname><given-names>G.</given-names></string-name></person-group><article-title>REDIportal: a comprehensive database of A-to-I RNA editing events in humans</article-title>. <source>Nucleic Acids Res.</source><year>2017</year>; <volume>45</volume>:<fpage>D750</fpage>–<lpage>D757</lpage>.<pub-id pub-id-type="pmid">27587585</pub-id></mixed-citation>
    </ref>
    <ref id="B25">
      <label>25.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lin</surname><given-names>C.H.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>S.C.</given-names></string-name></person-group><article-title>The cancer editome atlas: a resource for exploratory analysis of the adenosine-to-inosine RNA editome in cancer</article-title>. <source>Cancer Res.</source><year>2019</year>; <volume>79</volume>:<fpage>3001</fpage>–<lpage>3006</lpage>.<pub-id pub-id-type="pmid">31015229</pub-id></mixed-citation>
    </ref>
    <ref id="B26">
      <label>26.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ellrott</surname><given-names>K.</given-names></string-name>, <string-name><surname>Bailey</surname><given-names>M.H.</given-names></string-name>, <string-name><surname>Saksena</surname><given-names>G.</given-names></string-name>, <string-name><surname>Covington</surname><given-names>K.R.</given-names></string-name>, <string-name><surname>Kandoth</surname><given-names>C.</given-names></string-name>, <string-name><surname>Stewart</surname><given-names>C.</given-names></string-name>, <string-name><surname>Hess</surname><given-names>J.</given-names></string-name>, <string-name><surname>Ma</surname><given-names>S.</given-names></string-name>, <string-name><surname>Chiotti</surname><given-names>K.E.</given-names></string-name>, <string-name><surname>McLellan</surname><given-names>M.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Scalable open science approach for mutation calling of tumor exomes using multiple genomic pipelines</article-title>. <source>Cell Syst.</source><year>2018</year>; <volume>6</volume>:<fpage>271</fpage>–<lpage>281</lpage>.<pub-id pub-id-type="pmid">29596782</pub-id></mixed-citation>
    </ref>
    <ref id="B27">
      <label>27.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhao</surname><given-names>K.</given-names></string-name>, <string-name><surname>Lu</surname><given-names>Z.X.</given-names></string-name>, <string-name><surname>Park</surname><given-names>J.W.</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Xing</surname><given-names>Y.</given-names></string-name></person-group><article-title>GLiMMPS: robust statistical model for regulatory variation of alternative splicing using RNA-seq data</article-title>. <source>Genome Biol.</source><year>2013</year>; <volume>14</volume>:<fpage>R74</fpage>.<pub-id pub-id-type="pmid">23876401</pub-id></mixed-citation>
    </ref>
    <ref id="B28">
      <label>28.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sud</surname><given-names>A.</given-names></string-name>, <string-name><surname>Kinnersley</surname><given-names>B.</given-names></string-name>, <string-name><surname>Houlston</surname><given-names>R.S.</given-names></string-name></person-group><article-title>Genome-wide association studies of cancer: current insights and future perspectives</article-title>. <source>Nat. Rev. Cancer</source>. <year>2017</year>; <volume>17</volume>:<fpage>692</fpage>–<lpage>704</lpage>.<pub-id pub-id-type="pmid">29026206</pub-id></mixed-citation>
    </ref>
    <ref id="B29">
      <label>29.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Buniello</surname><given-names>A.</given-names></string-name>, <string-name><surname>MacArthur</surname><given-names>J.A.L.</given-names></string-name>, <string-name><surname>Cerezo</surname><given-names>M.</given-names></string-name>, <string-name><surname>Harris</surname><given-names>L.W.</given-names></string-name>, <string-name><surname>Hayhurst</surname><given-names>J.</given-names></string-name>, <string-name><surname>Malangone</surname><given-names>C.</given-names></string-name>, <string-name><surname>McMahon</surname><given-names>A.</given-names></string-name>, <string-name><surname>Morales</surname><given-names>J.</given-names></string-name>, <string-name><surname>Mountjoy</surname><given-names>E.</given-names></string-name>, <string-name><surname>Sollis</surname><given-names>E.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019</article-title>. <source>Nucleic Acids Res.</source><year>2019</year>; <volume>47</volume>:<fpage>D1005</fpage>–<lpage>D1012</lpage>.<pub-id pub-id-type="pmid">30445434</pub-id></mixed-citation>
    </ref>
    <ref id="B30">
      <label>30.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pers</surname><given-names>T.H.</given-names></string-name>, <string-name><surname>Timshel</surname><given-names>P.</given-names></string-name>, <string-name><surname>Hirschhorn</surname><given-names>J.N.</given-names></string-name></person-group><article-title>SNPsnap: a Web-based tool for identification and annotation of matched SNPs</article-title>. <source>Bioinformatics</source>. <year>2015</year>; <volume>31</volume>:<fpage>418</fpage>–<lpage>420</lpage>.<pub-id pub-id-type="pmid">25316677</pub-id></mixed-citation>
    </ref>
    <ref id="B31">
      <label>31.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ali</surname><given-names>M.</given-names></string-name>, <string-name><surname>Aittokallio</surname><given-names>T.</given-names></string-name></person-group><article-title>Machine learning and feature selection for drug response prediction in precision oncology applications</article-title>. <source>Biophys. Rev.</source><year>2019</year>; <volume>11</volume>:<fpage>31</fpage>–<lpage>39</lpage>.<pub-id pub-id-type="pmid">30097794</pub-id></mixed-citation>
    </ref>
    <ref id="B32">
      <label>32.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ye</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Hu</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>H.</given-names></string-name>, <string-name><surname>Liang</surname><given-names>K.</given-names></string-name>, <string-name><surname>Yuan</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Xiang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Ruan</surname><given-names>H.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Song</surname><given-names>A.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>H.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Characterization of hypoxia-associated molecular features to aid hypoxia-targeted therapy</article-title>. <source>Nat Metab</source>. <year>2019</year>; <volume>1</volume>:<fpage>431</fpage>–<lpage>444</lpage>.<pub-id pub-id-type="pmid">31984309</pub-id></mixed-citation>
    </ref>
    <ref id="B33">
      <label>33.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ruan</surname><given-names>H.</given-names></string-name>, <string-name><surname>Xiang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Ko</surname><given-names>J.</given-names></string-name>, <string-name><surname>Li</surname><given-names>S.L.</given-names></string-name>, <string-name><surname>Jing</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>X.Y.</given-names></string-name>, <string-name><surname>Ye</surname><given-names>Y.Q.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Mills</surname><given-names>T.</given-names></string-name>, <string-name><surname>Feng</surname><given-names>J.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Comprehensive characterization of circular RNAs in similar to 1000 human cancer cell lines</article-title>. <source>Genome Med.</source><year>2019</year>; <volume>11</volume>:<fpage>55</fpage>.<pub-id pub-id-type="pmid">31446897</pub-id></mixed-citation>
    </ref>
    <ref id="B34">
      <label>34.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jing</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>J.</given-names></string-name>, <string-name><surname>Ye</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Pan</surname><given-names>L.</given-names></string-name>, <string-name><surname>Deng</surname><given-names>H.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Diao</surname><given-names>L.</given-names></string-name>, <string-name><surname>Lin</surname><given-names>S.H.</given-names></string-name>, <string-name><surname>Mills</surname><given-names>G.B.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Multi-omics prediction of immune-related adverse events during checkpoint immunotherapy</article-title>. <source>Nat. Commun.</source><year>2020</year>; <volume>11</volume>:<fpage>4946</fpage>.<pub-id pub-id-type="pmid">33009409</pub-id></mixed-citation>
    </ref>
    <ref id="B35">
      <label>35.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Jing</surname><given-names>J.</given-names></string-name>, <string-name><surname>Ye</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Jing</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Li</surname><given-names>S.</given-names></string-name>, <string-name><surname>Hong</surname><given-names>W.</given-names></string-name>, <string-name><surname>Ruan</surname><given-names>H.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Hu</surname><given-names>Q.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Characterization of the dual functional effects of heat shock proteins (HSPs) in cancer hallmarks to aid development of HSP inhibitors</article-title>. <source>Genome Med</source>. <year>2020</year>; <volume>12</volume>:<fpage>101</fpage>.<pub-id pub-id-type="pmid">33225964</pub-id></mixed-citation>
    </ref>
    <ref id="B36">
      <label>36.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>J.H.</given-names></string-name>, <string-name><surname>Ruan</surname><given-names>H.</given-names></string-name>, <string-name><surname>Ye</surname><given-names>Y.Q.</given-names></string-name>, <string-name><surname>Krakowiak</surname><given-names>J.</given-names></string-name>, <string-name><surname>Hu</surname><given-names>Q.S.</given-names></string-name>, <string-name><surname>Xiang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Gong</surname><given-names>J.</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>B.Y.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>L.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer</article-title>. <source>Nat. Commun.</source><year>2019</year>; <volume>10</volume>:<fpage>4562</fpage>.<pub-id pub-id-type="pmid">31594934</pub-id></mixed-citation>
    </ref>
    <ref id="B37">
      <label>37.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ye</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Jing</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Li</surname><given-names>L.</given-names></string-name>, <string-name><surname>Mills</surname><given-names>G.B.</given-names></string-name>, <string-name><surname>Diao</surname><given-names>L.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>H.</given-names></string-name>, <string-name><surname>Han</surname><given-names>L.</given-names></string-name></person-group><article-title>Sex-associated molecular differences for cancer immunotherapy</article-title>. <source>Nat. Commun.</source><year>2020</year>; <volume>11</volume>:<fpage>1779</fpage>.<pub-id pub-id-type="pmid">32286310</pub-id></mixed-citation>
    </ref>
    <ref id="B38">
      <label>38.</label>
      <mixed-citation publication-type="journal"><collab>Consortium, I.T.P.-C.A.o.W.G.</collab><article-title>Pan-cancer analysis of whole genomes</article-title>. <source>Nature</source>. <year>2020</year>; <volume>578</volume>:<fpage>82</fpage>–<lpage>93</lpage>.<pub-id pub-id-type="pmid">32025007</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
